TB Research

Understanding the epidemiology of TB-HIV co-infection in Indonesia: evidence from the 2023 national TB registry

Machrumnizar M, Eryando T, Bachtiar A, Kusumaratna RK, Meiyanti M, Djuana E, Hidayah N, Alfiyyah A

BMJ public health · 2025-12

Abstract

Introduction Tuberculosis (TB) and HIV co-infection remain a significant public health challenge in Indonesia. Therefore, this study aims to identify the determinants and epidemiological characteristics of TB-HIV co-infection using data from the 2023 national TB registry. Methods The study procedures were carried out using a cross-sectional design, analysing univariate, bivariate and multivariate associations between TB-HIV coinfection status and demographic, clinical and health service factors among patients with TB. Results Among 22 698 patients with TB, 94.8% were HIV negative, with a predominance of males (58.8%) and adults aged 30-59 years (49.8%). The majority of the patients were treated in healthcare facilities located in Western Indonesia, had pulmonary TB (93.8%), bacteriological diagnosis (55.5%) and achieved a cure (85.9%), while the remaining 14.1% included patients who died, were lost to follow-up, or had incomplete treatment outcomes. The most common nutritional status among patients was normal nutritional status (44.4%). In the multivariate analysis, clinical diagnosis remained the strongest predictor of TB-HIV co-infection (OR 2.446; 95% CI 2.154 to 2.778; p Conclusions This study highlights TB-HIV co-infection as the primary outcome, emphasising the role of demographic, clinical, nutritional and regional disparities in influencing co-infection risks. The findings underscore the need for integrated TB-HIV diagnostic and management strategies, including nutritional support and targeted interventions focusing on high-risk populations and health service accessibility to strengthen early detection and treatment outcomes.